Case Control Study to Identify Modifiable Risk Factors for Colorectal and Breast Cancer in Nigeria
NCT ID: NCT05044689
Last Updated: 2025-03-21
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
RECRUITING
800 participants
OBSERVATIONAL
2021-04-12
2026-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Based on the existing ARGO platform where a current colorectal cancer study is going on, approximately 400 patients with a prior diagnosis or a new diagnosis will be recruited into this study. Comparatively, we will select our 400 controls from two groups of participants who are free of cancer and gastrointestinal diseases.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Nigerian Breast Cancer Risk-Reduction Study
NCT05834933
Tablet-based Mobile Health Ultrasound for Point-of-care Breast Cancer Diagnosis in Nigeria (Mobile Health: Technology and Outcomes in Low and Middle-Income Countries)
NCT05561842
Tablet-based Mobile Health Ultrasound for Point-of-care Breast Cancer Diagnosis in Nigeria
NCT04501419
Improving Access to Breast Cancer Screening and Treatment in Nigeria: The Triple Mobile Assessment and Patient Navigation Model
NCT05321823
Patterns of Breast Cancer Management and Prognosis of Breast Cancer in China
NCT04076111
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
CASE_CONTROL
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Colorectal Cancer (Cases)
Based on the existing ARGO (African Colorectal Cancer Group) platform where a current colorectal cancer study is going on, 400 patients with a prior diagnosis and a new diagnosis will be recruited into this study.
Questionnaire
Questionnaire containing questions regarding diet, physical activity, past medical history and life style practices.
Bioimpedance/Body Composition Unit
Patients will provide information on body composition through the use of a bioimpedance machine which measures the body mass index, fat and total body water.
Controls
We will select our 400 controls from two groups of participants who are free of cancer and gastrointestinal diseases. First, we will leverage community mobilization groups to identify and recruit a target group of 200 community-based population controls. Second, we will identify and recruit the remaining 200 controls from those seeking care in the Outpatient Health Center at OAU, which sees \~50-60 patients per day as part of routine care.
Questionnaire
Questionnaire containing questions regarding diet, physical activity, past medical history and life style practices.
Bioimpedance/Body Composition Unit
Patients will provide information on body composition through the use of a bioimpedance machine which measures the body mass index, fat and total body water.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Questionnaire
Questionnaire containing questions regarding diet, physical activity, past medical history and life style practices.
Bioimpedance/Body Composition Unit
Patients will provide information on body composition through the use of a bioimpedance machine which measures the body mass index, fat and total body water.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Control Group - Patients must not have a diagnosis of cancer.
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Memorial Sloan Kettering Cancer Center
OTHER
Lagos State University
OTHER
University of Ilorin Teaching Hospital
OTHER
Federal Medical Centre, Owo
INDUSTRY
University of Maiduguri Teaching Hospital
UNKNOWN
National Hospital, Abuja
OTHER_GOV
Obafemi Awolowo University Teaching Hospital
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Olusegun Alatise
MB.ChB (Ife), M.Sc, FWACS, FMCS, FACS
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Obafemi Awolowo University Teaching Hospitals
Ile-Ife, Osun State, Nigeria
Countries
Review the countries where the study has at least one active or historical site.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
ERC/2018/06/01
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.